Drug & Medication
Table of Contents
Providing clarity regarding generic launch timing that will shape the market around Eli Lilly's antidepressant Cymbalta and Celgene's oncology drug Revlimid.Detailed analysis of the likely date of generic entry for Cymbalta and RevlimidAnalysis of both products' position in their companies total prescription pharma portfolio...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Shadi
+1 718 618 4897
REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. ...
The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets; the ...
The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, ...
... Report description ophthalmic drugs market is expected to reach usd 21.6 Billion globally in 2018: transparency market research according to a new market report published by transparency ...
... The classes of medications not primarily used to preserve life or major body system functioning and thus of little or no value to the employer as well as those that may achieve outcomes of some value ...
Reportlinker.com © Copyright 2014. All rights reserved.